The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis
Oncology Research and Treatment · 2021 · 44 (11) · 622-636
DOI: 10.1159/000518848 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Oncology Research and Treatment, online erschienen am 03.09.2021. Verfasst von Eva Elisabeth van Grinsven und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology & Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Brain Neoplasms, Radiosurgery. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background & Objectives: Radiotherapy is standard treatment for patients with brain metastases (BMs), although it may lead to radiation-induced cognitive impairment. This review explores the impact of whole-brain radiotherapy (WBRT) or stereotactic radiosurgery (SRS) on cognition.
Methods
The PRISMA guidelines were used to identify articles on PubMed and EmBase reporting on objective assessment of cognition before, and at least once after radiotherapy, in adult patients with nonresected BMs.
Results
Of the 867 records screened, twenty articles (14 unique studies) were included. WBRT lead to decline in cognitive performance, which stabilized or returned to baseline in patients with survival of at least 9–15 months. For SRS, a decline in cognitive performance was sometimes observed shortly after treatment, but the majority of patients returned to or remained at baseline until a year after treatment.
Conclusions
These findings suggest that after WBRT, patients can experience deterioration over a longer period of time. The cognitive side effects of SRS are transient. Therefore, this review advices to choose SRS as this will result in lowest risks for cognitive adverse side effects, irrespective of predicted survival. In an already cognitively vulnerable patient population with limited survival, this information can be used in communicating risks and aid in making educated decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology & Neurosurgery, University Medical Center Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.
- Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
- Department of Experimental Psychology and Helmholtz Institute, Utrecht University, Utrecht, The Netherlands.
Zitieren
APA
van Grinsven, E. E., Nagtegaal, S. H. J., Verhoeff, J. J. C., & van Zandvoort, M. J. E. (2021). The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis. Oncology Research and Treatment, 44(11), 622-636. https://doi.org/10.1159/000518848
Vancouver
van Grinsven EE, Nagtegaal SHJ, Verhoeff JJC, van Zandvoort MJE. The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis. Oncology Research and Treatment. 2021;44(11):622-636. doi:10.1159/000518848
BibTeX
@article{vanGrinsven2021,
author = {van Grinsven, Eva Elisabeth and Nagtegaal, Steven H J and Verhoeff, Joost J C and van Zandvoort, Martine J E},
title = {The Impact of Stereotactic or Whole Brain Radiotherapy on Neurocognitive Functioning in Adult Patients with Brain Metastases: A Systematic Review and Meta-Analysis},
journal = {Oncology Research and Treatment},
year = {2021},
volume = {44},
number = {11},
pages = {622--636},
doi = {10.1159/000518848}
}
EUVIMED